Avisa Pharma Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Avisa Pharma Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10482
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; and avisar spec, a point-of-care instrument that is used for measuring exhaled carbondioxide. Its AV-U13 drug for inhalation and nebulizer are packaged in a disposable breath collection kit to test the presence of pathogens. Avisa Pharma’s avisa breath test kit offers immediate information of the presence of certain urease pathogens in the lung. The company provides products which find clinical applications for pneumonia in the emergency department, ventilator associated pneumonia, chronic obstructive pulmonary disease exacerbations and tuberculosis, among others. It caters to hospitals, emergency departments, coronary care units, nursing units, urgent care centers and retail clinics, among others. Avisa Pharma is headquartered in Santa Fe, New Mexico, the US.

Avisa Pharma Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avisa Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avisa Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avisa Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avisa Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Avisa Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avisa Pharma Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Avisa Pharma Raises Additional USD2.5 Million in Venture Financing 10
Avisa Pharma Raises USD0.9 Million in Venture Financing 11
Avisa Pharma Raises USD3.6 Million in Venture Financing 12
Avisa Pharma Raises US$3.2 Million In Venture Financing 13
Avisa Pharma Inc – Key Competitors 14
Avisa Pharma Inc – Key Employees 15
Avisa Pharma Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Avisa Pharma Inc, Medical Equipment, Key Facts 2
Avisa Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Avisa Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avisa Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avisa Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avisa Pharma Inc, Deals By Market, 2012 to YTD 2018 8
Avisa Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avisa Pharma Raises Additional USD2.5 Million in Venture Financing 10
Avisa Pharma Raises USD0.9 Million in Venture Financing 11
Avisa Pharma Raises USD3.6 Million in Venture Financing 12
Avisa Pharma Raises US$3.2 Million In Venture Financing 13
Avisa Pharma Inc, Key Competitors 14
Avisa Pharma Inc, Key Employees 15

List of Figures
Avisa Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Avisa Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Avisa Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Avisa Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Avisa Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avisa Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Avisa Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avisa Pharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Avisa Pharma Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Philippine National Bank:企業の戦略・SWOT・財務分析
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Telecom Argentina S.A.:戦略・SWOT・企業財務分析
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • VisionQuest Biomedical LLC:企業の製品パイプライン分析2018
    Summary VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include eyestar, DR-RACS, and neurotherm. Its eyestar product is a total eye disease screening program package, DR-RACS is an automated …
  • Mologen AG:企業のM&A・事業提携・投資動向
    Mologen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mologen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Klockner Pentaplast GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Orlando Utilities Commission:電力:M&Aディール及び事業提携情報
    Summary Orlando Utilities Commission (OUC) is a municipally-owned public utility that provides water and electric services. The commission generates, transmits, and distributes electricity and water to residential and commercial customers. It also constructs, operates and maintains electric and wate …
  • Advocate Health Care-製薬・医療分野:企業M&A・提携分析
    Summary Advocate Health Care (Advocate Health) is a nonprofit health system that provides health care services. It provides health care services such as inpatient acute and non-acute care, primary and specialty physician services and various outpatient services to communities in Illinois. The organi …
  • Targa Resources Corp.:企業の戦略・SWOT・財務情報
    Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acorda Therapeutics Inc (ACOR):企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Versartis Inc (VSAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Versartis Inc (Versartis) is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GHD) that is designed to reduc …
  • Stockland Corporation Ltd:企業の戦略・SWOT・財務情報
    Stockland Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Stockland Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enel SpA (ENEL):電力:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • Blue Dolphin Energy Co (BDCO):企業の財務・戦略的SWOT分析
    Summary Blue Dolphin Energy Co (Blue Dolphin) operates as an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolph …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Posco Daewoo Corp (047050):企業の財務・戦略的SWOT分析
    Posco Daewoo Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Golden Dawn Minerals Inc (GOM):企業の財務・戦略的SWOT分析
    Summary Golden Dawn Minerals Inc (Golden Dawn) is a mining and mineral exploration and development company. it offers acquisition, exploration, operations, management, production, and development of gold, uranium, silver, iron, lead, zinc, base metals, precious metals, and mineral resource deposit p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆